Tag: Cancer: Brain

Several tumor and treatment factors were tied to risk for poorer outcomes

Significant improvement seen in progression-free survival and in time to next intervention for vorasidenib versus placebo

Increased risk of intracranial tumors, leukemia, and lymphoma by age 25 seen with exposure to four or more CT scans during childhood

GD2-targeted CAR T cells expanded in vivo, and were detectable in peripheral blood up to 30 months after infusion

Risk for cancer transmission lower than thought, and long-term transplant outcomes favorable

Individuals unemployed due to tumor report more functional impairment with walking, washing, dressing and reduced HRQoL

Survival outcomes improved with extent of tumor resection ≥75 percent for patients with grade 2 glioma

Black patients more likely to receive recommendation against resection for glioblastoma, meningioma, pituitary adenoma, vestibular schwannoma

Catheter pump system capable of CED of topotecan well tolerated and active in recurrent glioblastoma

Guideline recommendations support reduction in volume of brain irradiation while attempting to maximize disease control